Semaglutide and Drug Craving: Emerging Perspectives in Addiction Psychiatry
Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist used for type 2 diabetes and obesity, has attracted interest as a potential modulator of drug craving and substance-related reinforcement. This mini-review examines mechanistic and clinical evidence across cocaine, alcohol, nicotine, and opioid use disorde...